BioGene Therapeutics Inc. funding
BioGene Therapeutics Inc., a biotechnology company based in Austin, TX (founded 2024), filed a Form D with the SEC on August 7, 2026 and reported $3M raised. It filed 5 new offerings in this period, totaling $11.1M.
Amount raised$3M
Offering size$3M
Filed with the SECAugust 7, 2026
First saleJune 5, 2026
IndustryBiotechnology
SecuritiesOptions or warrants, Security to be acquired on exercise
LocationAustin, TX
Founded2024
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 7
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| August 7, 2026 | $3M | $3M | Options or warrants, Security to be acquired on exercise |
| August 6, 2026 | $3M | $3M | Options or warrants, Security to be acquired on exercise |
| August 6, 2026 | $250K | $250K | Options or warrants, Security to be acquired on exercise |
| August 6, 2026 | $250K | $250K | Options or warrants, Security to be acquired on exercise |
| July 23, 2026 | $4.5M | $4.5M | Options or warrants, Security to be acquired on exercise |
Other health care rounds in Texas
OncoNano Medicine, Inc.$10.1M · Oct 8BiotechnologySolaris Endovascular Inc.$5M · Oct 1BiotechnologyTransformer TX Holdings, LLC$4.1M · Nov 9Hospitals and PhysiciansTeos Health, LLC$3.1M · Oct 30Other Health CareCerenome, Inc.$3M · Sep 18Other Health CareFibroBiologics, Inc.$1.2M · Oct 13PharmaceuticalsPressio, Inc.$544K · Oct 6Other Health CareIctero Medical, Inc.$344K · Nov 5Other Health Care